Immune System Diseases Completed Phase 2 Trials for Tacrolimus (DB00864)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02294552Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCTTreatment